QLGN实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system...

Stats
今日成交量	9 087.00
平均成交量	65 834.00
市值	1.83M
EPS	$-0.640 ( 2023-11-14 )
下一个收益日期	( $-0.520 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0.00700 (2.41%)

Insider Trading

Date	Person	Action	Amount	type
2022-07-11	Abdul-ahad Wajdi	Buy	80 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Arshad Tariq	Buy	102 000	Stock Option (Right to Buy)
2022-07-11	Ritter Ira E.	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 89 transactions
Buy: 8 588 032 \| Sell: 1 076 061

Qualigen Therapeutics Inc 相关性

10 最正相关
LYEL	0.959
ARQQ	0.958
WISA	0.956
FATE	0.954
QTEK	0.953
RPID	0.953
STRC	0.951
NKTX	0.951
LYRA	0.945
GROM	0.944

10 最负相关
LRFC	-0.955
NWFL	-0.954
STAY	-0.944
LUNA	-0.941
TIPT	-0.939
IBEX	-0.938
IVAC	-0.936
PEBK	-0.935
GLLI	-0.931
CCRC	-0.931

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Qualigen Therapeutics Inc 财务报表

Annual	2023
营收:	$0
毛利润:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2023
营收:	$0
毛利润:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2022
营收:	$4.98M
毛利润:	$680 801 (13.66 %)
EPS:	$-5.48

FY	2021
营收:	$5.65M
毛利润:	$1.32M (23.37 %)
EPS:	$-6.10

Financial Reports:

No articles found.

Qualigen Therapeutics Inc

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.